Oxytocin alleviates liver fibrosis via hepatic macrophages
JHEP Reports · 2024-06 · 6 (6) · 101032
DOI: 10.1016/j.jhepr.2024.101032 ↗Kurz gefasst
Fachartikel in der Zeitschrift JHEP Reports, 2024-06. Verfasst von Xiangyu Zhai und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, The Second Hospital of Shangdong University, Jinan, China. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shandong Province Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background & Aims: Previous studies demonstrated oxytocin treatment effectiveness in reducing mortality and reversing liver fibrosis in mice. However, the underlying mechanism remains obscure, given the absence of oxytocin receptor expression in hepatic stellate cells, the primary liver fibrosis effector cells.
Methods
A comprehensive map of cell populations in fibrotic liver was generated using single-cell sequencing. The map enabled our study of the target cells of oxytocin action in the liver in more dimensions. Furthermore, we elucidated the mechanism of the oxytocin signaling system in hepatic macrophages using oxytocin receptor-specific knockout mice and liver fibrosis animal models.
Results
The carbon tetrachloride-induced hepatic fibrosis and bile duct ligation hepatic fibrosis mouse models demonstrated that oxytocin reversed hepatic fibrosis in mice. The mapped liver cell populations demonstrated that oxytocin promoted the phenotypic switch from Ly6high to Ly6Clow in myeloid-derived macrophages. The phenotypic control of oxytocin signaling system activation on this phenotypic switch was validated using myeloid-specific oxytocin receptor knockout mice. Subsequent studies demonstrated that the calcium inward flow induced by oxytocin receptor activation activated the key orphan nuclear receptor NR4A1, which controls macrophage phenotypic switching. Specifically, calcium ions activated CREB, a key target regulator of NR4A1 expression.
Conclusions
The findings established hepatic macrophages as a hub responsible for the oxytocin-mediated alleviation of liver fibrosis. This study revealed a novel pathway where oxytocin regulates macrophage phenotype. Impact and implications: Previous studies revealed for the first time the expression of oxytocin receptors in the liver. The present study shows that oxytocin reverses hepatic fibrosis and that hepatic macrophages are the central hub of oxytocin-mediated alleviation of hepatic fibrosis by promoting a phenotypic switch in hepatic macrophages, transitioning from Ly6high to Ly6Clow expression. The present study reveals a novel pathway by which oxytocin regulates macrophage phenotype. In addition, the potential applications of oxytocin and its analogues, as traditional drugs for clinical application, in the treatment of liver fibrosis deserve to be further explored.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, The Second Hospital of Shangdong University, Jinan, China.
- Hepatobiliary Surgery Research Center of Shandong University, Jinan, China.
- Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.
- Organ Transplant Department, Qilu Hospital of Shangdong University, Jinan, China.
- Department of General Surgery, Shandong Provincial Qianfoshan Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
- Pathology Tissue Bank, Qilu Hospital of Shandong University, Jinan, China.
Förderung
- Shandong Province Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Zhai, X., Zhang, H., Xia, Z., Liu, M., Du, G., Jiang, Z., Zhou, H., Luo, D., Dou, D., Li, J., Wang, W., Li, X., & Jin, B. (2024). Oxytocin alleviates liver fibrosis via hepatic macrophages. JHEP Reports, 6(6), 101032. https://doi.org/10.1016/j.jhepr.2024.101032
Vancouver
Zhai X, Zhang H, Xia Z, Liu M, Du G, Jiang Z, et al. Oxytocin alleviates liver fibrosis via hepatic macrophages. JHEP Reports. 2024;6(6):101032. doi:10.1016/j.jhepr.2024.101032
BibTeX
@article{Zhai2024,
author = {Zhai, Xiangyu and Zhang, Hao and Xia, Zhijia and Liu, Mingkun and Du, Gang and Jiang, Zhengchen and Zhou, Huaxin and Luo, Dan and Dou, Dandan and Li, Jingxin and Wang, Wei and Li, Xiaosong and Jin, Bin},
title = {Oxytocin alleviates liver fibrosis via hepatic macrophages},
journal = {JHEP Reports},
year = {2024},
volume = {6},
number = {6},
pages = {101032},
doi = {10.1016/j.jhepr.2024.101032}
}
EUVIMED